Golden
BioAmber

BioAmber

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals.

All edits

Edits on 19 Sep 2019
Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 19 Sep 2019 12:39 am
Edits made to:
Article (+8/-8 characters)

Article

BioAmber is a chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals that is headquartered in MontrealMontreal, Quebec and was founded in 2008. The company uses industrial biotechnology and chemical catalysis to create chemicals for several consumer products such as plastics, personal care products, resins, and food additives from renewable feedstocks.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 19 Sep 2019 12:03 am
Edits made to:
Article (+7/-7 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in Sarnia, OntarioOntario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 Sep 2019 11:56 pm
Edits made to:
Article (+22/-22 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock ExchangeToronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 Sep 2019 11:56 pm
Edits made to:
Article (+23/-23 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock ExchangeNew York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 Sep 2019 11:56 pm
Edits made to:
Article (+2/-2 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a USUS and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 Sep 2019 11:49 pm
Edits made to:
Article (+14/-14 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public marketspublic markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 Sep 2019 11:47 pm
Edits made to:
Article (+6/-6 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and CanadaCanada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 Sep 2019 11:45 pm
Edits made to:
Article (+6/-6 characters)

Article

On October 26, 2018 BioAmber's non-operational plant in SarniaSarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 18 Sep 2019 9:16 pm
Edits made to:
Article (+6/-6 characters)

Article

BioAmber is a chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals that is headquartered in Montreal, QuebecQuebec and was founded in 2008. The company uses industrial biotechnology and chemical catalysis to create chemicals for several consumer products such as plastics, personal care products, resins, and food additives from renewable feedstocks.

Dawson Sewell
Dawson Sewell edited on 18 Sep 2019 12:34 pm
Edits made to:
Description (+1 characters)
Article (+1085 characters)
Topic thumbnail

BioAmber

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals.

Article

BioAmber is a chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals that is headquartered in Montreal, Quebec and was founded in 2008. The company uses industrial biotechnology and chemical catalysis to create chemicals for several consumer products such as plastics, personal care products, resins, and food additives from renewable feedstocks.

Acquisitions

LYC Biotechnology

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Edits on 9 Sep 2019
Dawson Sewell
Dawson Sewell edited on 9 Sep 2019 1:58 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 12 Jun 2019
Golden AI
Golden AI edited on 12 Jun 2019 10:10 pm
Edits made to:
Infobox (+1 properties)

Infobox

Golden AI
Golden AI edited on 12 Jun 2019 9:59 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 21 Jan 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan 2019 10:11 pm
Edits made to:
Infobox (+1/-1 properties)

Infobox

Edits on 9 Jan 2019
Golden AI
Golden AI edited on 9 Jan 2019 10:05 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 12 Dec 2018
Golden AI"Import data"
Golden AI edited on 12 Dec 2018 1:10 am
Edits made to:
Infobox (+5 properties)
People (+5 rows) (+10 cells) (+107 characters)
Categories (+1 topics)

People

Name
Role
Related Golden topics

Curtis Gunn

Investor



Louise Batchelor

Employee



Patrick Piot

Employee



Paul Petersen

Employee



Sara Weinheimer

Investor



Infobox

Categories

Edits on 20 Sep 2018
Golden AI"Import structured data from Wikidata.org: https://www.wikidata.org/wiki/Q16951804"
Golden AI edited on 20 Sep 2018 12:52 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 13 Sep 2018
Golden AI"Import structured data from Wikidata.org: https://www.wikidata.org/wiki/Q16951804"
Golden AI edited on 13 Sep 2018 7:06 am
Edits made to:
Infobox (+2 properties)

Infobox

Headquarters location
Edits on 1 Sep 2018
Golden AI"Update description"
Golden AI edited on 1 Sep 2018 12:14 am
Edits made to:
Description (+113/-21 characters)
Topic thumbnail

BioAmber

Biotechnology company

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals

Edits on 26 Jul 2018
Jude Gomila
Jude Gomila edited on 26 Jul 2018 1:34 am
Edits made to:
Topic thumbnail

BioAmber

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals.